Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Prospective, Open-Label, Ex Vivo Comparison Study of Lymphoseek® and Vital Blue Dye (VBD) as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) Patients' Excised Colon w/ Abdominal Lymphatic Bed

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT01902953
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-28T10:38:08.179920+00:00
Published At
2020-05-20T00:00:00+00:00
Record Updated At
2021-06-23
Results Posted At
2020-05-20
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Colon Cancer", "Rectal Cancer"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2021-06-23"
protocolSection.identificationModule.nctId
"NCT01902953"
protocolSection.identificationModule.officialTitle
"Prospective, Open-Label, Ex Vivo Comparison Study of Lymphoseek\u00ae and Vital Blue Dye (VBD) as Lymphoid Tissue Targeting Agents in Colon Cancer(CNC) Patients\u0027 Excised Colon w/ Abdominal Lymphatic Bed"
protocolSection.statusModule.overallStatus
"COMPLETED"
protocolSection.designModule.phases
["PHASE2"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
"2020-05-20"

Study condition terms

  • Colon Cancer (protocolSection.conditionsModule.conditions)
  • Rectal Cancer (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.